DK552280A - Partikler til binding af biologisk aktive substanser praeparat paa basis af disse partikler og fremgangsmaade til fremstilling deraf - Google Patents

Partikler til binding af biologisk aktive substanser praeparat paa basis af disse partikler og fremgangsmaade til fremstilling deraf

Info

Publication number
DK552280A
DK552280A DK552280A DK552280A DK552280A DK 552280 A DK552280 A DK 552280A DK 552280 A DK552280 A DK 552280A DK 552280 A DK552280 A DK 552280A DK 552280 A DK552280 A DK 552280A
Authority
DK
Denmark
Prior art keywords
particles
procedures
producing
biologically active
active substances
Prior art date
Application number
DK552280A
Other languages
English (en)
Other versions
DK160288B (da
DK160288C (da
Inventor
Z Riedl
L Sztankov
I Horvath
Original Assignee
Human Oltoanyagtermelo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Oltoanyagtermelo filed Critical Human Oltoanyagtermelo
Publication of DK552280A publication Critical patent/DK552280A/da
Publication of DK160288B publication Critical patent/DK160288B/da
Application granted granted Critical
Publication of DK160288C publication Critical patent/DK160288C/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK552280A 1979-12-27 1980-12-23 Fremgangsmaade til fremstilling af liposomer, til hvilke der er bundet biologisk aktive substanser DK160288C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU79HU299A HU184141B (en) 1979-12-27 1979-12-27 Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
HUHU000299 1979-12-27

Publications (3)

Publication Number Publication Date
DK552280A true DK552280A (da) 1981-06-28
DK160288B DK160288B (da) 1991-02-25
DK160288C DK160288C (da) 1991-08-05

Family

ID=10997378

Family Applications (1)

Application Number Title Priority Date Filing Date
DK552280A DK160288C (da) 1979-12-27 1980-12-23 Fremgangsmaade til fremstilling af liposomer, til hvilke der er bundet biologisk aktive substanser

Country Status (21)

Country Link
US (1) US4396630A (da)
JP (1) JPS57112334A (da)
BE (1) BE886884A (da)
CA (1) CA1165237A (da)
CH (1) CH655246A5 (da)
CS (1) CS241478B2 (da)
DD (1) DD158738A5 (da)
DE (1) DE3048815A1 (da)
DK (1) DK160288C (da)
ES (1) ES498048A0 (da)
FR (1) FR2472386B1 (da)
GB (1) GB2066203B (da)
HU (1) HU184141B (da)
IT (1) IT1150073B (da)
NL (1) NL8007041A (da)
PL (1) PL228755A1 (da)
PT (1) PT72261B (da)
RO (1) RO81371A (da)
SE (1) SE453537B (da)
SU (1) SU1487802A3 (da)
YU (1) YU44413B (da)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4598051A (en) * 1980-03-12 1986-07-01 The Regents Of The University Of California Liposome conjugates and diagnostic methods therewith
US4806466A (en) * 1981-10-29 1989-02-21 The Regents Of The University Of California Cell agglutination reagent comprising conjugates of antibody covalently bound to liposomes
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
DD247570A3 (de) * 1983-01-14 1987-07-15 Univ Berlin Humboldt Vesikulaeres trenn-, fuell- und traegermaterial
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US4619904A (en) * 1984-10-29 1986-10-28 General Electric Company Agglutinating immunoassay using protein-coated liquid droplets
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
ATE68686T1 (de) * 1985-10-31 1991-11-15 Kv Pharm Co System zum freigeben von stoffen in der vagina.
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US4790987A (en) * 1985-11-15 1988-12-13 Research Corporation Viral glycoprotein subunit vaccine
CA1338736C (fr) * 1986-12-05 1996-11-26 Roger Baurain Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
WO1990001948A1 (en) * 1988-08-25 1990-03-08 The Liposome Company, Inc. Influenza vaccine and novel adjuvants
ATE118096T1 (de) * 1988-12-22 1995-02-15 Baxter Diagnostics Inc Lipohaptene und verwendung trägergebundener lipohaptene im immuntest.
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
JPH07113641B2 (ja) * 1989-11-17 1995-12-06 積水化学工業株式会社 梅毒診断試薬の製造方法
NL9000207A (da) * 1990-01-29 1991-08-16 Duphar Int Res
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
AU654824B2 (en) * 1990-06-29 1994-11-24 Chiron Corporation Vaccine compositions containing liposomes
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
WO1992004887A1 (fr) * 1990-09-25 1992-04-02 Kyowa Hakko Kogyo Co., Ltd. Production de lymphocites t cytotoxiques
US6048531A (en) * 1991-04-15 2000-04-11 Albany Medical College Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies
US5336507A (en) * 1992-12-11 1994-08-09 Sterling Winthrop Inc. Use of charged phospholipids to reduce nanoparticle aggregation
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
AUPM500494A0 (en) * 1994-04-12 1994-05-05 Minister For Agriculture & Rural Affairs For The State Of New South Wales, The Composition for use in increasing mucosal immunity
DE60136490D1 (de) * 2000-11-09 2008-12-18 Neopharm Inc Sn-38-lipidkomplexe und verfahren zu ihrer verwendung
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
WO2003075889A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
WO2004035032A2 (en) * 2002-08-20 2004-04-29 Neopharm, Inc. Pharmaceutical formulations of camptothecine derivatives
US20060030578A1 (en) * 2002-08-20 2006-02-09 Neopharm, Inc. Pharmaceutically active lipid based formulation of irinotecan
KR101301653B1 (ko) * 2002-10-29 2013-08-30 트랜세이브, 인코포레이티드 항감염제의 지속적인 방출
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
WO2006090816A1 (ja) * 2005-02-25 2006-08-31 Mie University リポソームワクチンの作製法
JP5324223B2 (ja) 2005-12-08 2013-10-23 トランセイブ， インク． 肺感染症を治療する抗感染薬の脂質ベースの組成物及びその使用法
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
PL2852391T3 (pl) 2012-05-21 2022-04-11 Insmed Incorporated Układy do leczenia infekcji płuc
MX2015006681A (es) 2012-11-29 2016-04-06 Insmed Inc Formulaciones de vancomicina estabilizadas.
SMT202000516T1 (it) 2014-05-15 2020-11-10 Insmed Inc Metodi per trattamento di infezioni micobatteriche polmonati non tubercolari
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
WO2019213398A1 (en) 2018-05-02 2019-11-07 Insmed Incorporated Methods for the manufacture of liposomal drug formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
JPS5126213A (ja) * 1974-08-21 1976-03-04 Tanabe Seiyaku Co Johoseibiryushiseizaino seiho
GB1564500A (en) * 1975-09-29 1980-04-10 Wellcome Found Biological preparations
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
IT1110989B (it) * 1979-01-19 1986-01-13 Erba Farmitalia Forme farmaceutiche costitutite da liposomi e procedimenti relativi
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
JPS55118415A (en) * 1979-02-28 1980-09-11 Pii Papahadojiyopo Dometoriosu Method of encapsulating biologically active substance in lipoid cell

Also Published As

Publication number Publication date
SU1487802A3 (ru) 1989-06-15
BE886884A (fr) 1981-06-29
RO81371A (ro) 1984-04-02
DK160288B (da) 1991-02-25
PL228755A1 (da) 1982-02-15
DD158738A5 (de) 1983-02-02
JPS57112334A (en) 1982-07-13
FR2472386B1 (da) 1985-08-23
SE8009068L (sv) 1981-06-28
CA1165237A (en) 1984-04-10
ES8201316A1 (es) 1981-12-16
SE453537B (sv) 1988-02-08
US4396630A (en) 1983-08-02
NL8007041A (nl) 1981-07-16
PT72261A (en) 1981-01-01
DK160288C (da) 1991-08-05
FR2472386A1 (da) 1981-07-03
RO81371B (ro) 1983-11-02
GB2066203B (en) 1984-01-11
CH655246A5 (de) 1986-04-15
IT1150073B (it) 1986-12-10
JPH0314814B2 (da) 1991-02-27
GB2066203A (en) 1981-07-08
ES498048A0 (es) 1981-12-16
YU329080A (en) 1984-04-30
CS241478B2 (en) 1986-03-13
YU44413B (en) 1990-08-31
PT72261B (en) 1981-11-05
CS924680A2 (en) 1985-07-16
DE3048815A1 (de) 1981-09-10
HU184141B (en) 1984-07-30
IT8026950A0 (it) 1980-12-24

Similar Documents

Publication Publication Date Title
DK312985D0 (da) Fremgangsmaade ved og anlaeg til tilberedning af plastmateriale paa basis af butylgummi
DK30283D0 (da) Materialer og fremgangsmade til fremstilling af dialyseoploesninger indeholdende bicarbonationer
DK381579A (da) Fremgangsmaade til fremstilling af antioxygenstoffer og anvedelse af disse stoffer
DK577883A (da) Dna-struktur og fremgangsmaade til fremstilling af et polypeptid paa basis heraf
DK185880A (da) Glasfibermaatte og fremgangsmaade til frmstilling af samme
DK412284D0 (da) Vacciner baseret paa membran-bundne proteiner og fremgangsmaade til fremstilling deraf
DK104983D0 (da) Fremgangsmade til fremstilling af biologisk aktive polysaccharidkoncentrater
DK538582A (da) Elektromekanisk transducer og fremgangsmaade til justering af samme
DK151210C (da) Apparat til vejning af pulverformet materiale og vaeske og blanding af pulvret i vaesken
DK362483A (da) Varmeisoleret ledningsroer og fremgangsmaade til fremstilling af samme
DK44381A (da) Fremgangsmaade og saet til fremstilling af taage
DK232679A (da) Nydelsesmiddel paa basis af kakaosmoer og fremgangsmaade til frestilling deraf
DK171585D0 (da) Fremgangsmaade til fremstilling af rismateriale og produkt, fremstillet derved
DK366980A (da) Praeparater paa basis af lysin til fodring af dyr og fremgangsmaade til fremstilling deraf
DK155905C (da) Stabiliseret herbicisammensaetning baseret paa meta-biscarbamater, og en fremgangsmaade til anvendelse af samme
DK46579A (da) Fremgangsmaade til fremstilling af et materiale baseret paa blod og materiale fremstillet herved
DK410383A (da) Poroest polytetrafluorethylenmateriale samt fremgangsmaade til fremstilling af samme
DK312983D0 (da) Kobling til hurtig forbindelse af elementer i form af roer, staenger og lignende
DK441177A (da) Filtermateriale og fremgangsmaade til fremstilling af samme
DK28883A (da) Dentalkonstruktion og fremgangsmaade til fremstilling af samme
DK160678C (da) Fremgangsmaade og apparat til komprimering af kornede formmaterialer
DK549481A (da) Fotopolymeriserbart registreringsmateriale og fremgangsmaade til fremstilling af reliefforme paa basis heraf
DK476483D0 (da) Apparat til komprimering af kornede formmaterialer
DK482583D0 (da) Dna-sekvens, dna-strukturer og fremgangsmade til fremstilling af penicillin-acylase under anvendelse deraf
DK149944C (da) Polymert dispergeringsmiddel og fremgangsmaader til fremstilling af samme